INVO Fertility (IVF) EPS (Weighted Average and Diluted) Growth (5y) (2016 - 2025)
INVO Fertility (IVF) EPS (Weighted Average and Diluted) Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.10 Mn | 4.75 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -16.42% |
| Jun 30, 2025 | -96.70% |
| Mar 31, 2025 | -112.38% |
| Dec 31, 2024 | 182.93% |
| Sep 30, 2024 | -151.56% |
| Jun 30, 2024 | -275.48% |
| Mar 31, 2024 | -379.59% |
| Dec 31, 2023 | -551.83% |
| Sep 30, 2023 | -222.72% |
| Jun 30, 2023 | -214.16% |
| Mar 31, 2023 | -426.89% |
| Dec 31, 2022 | -402.10% |
| Sep 30, 2022 | -424.77% |
| Jun 30, 2022 | -444.02% |
| Mar 31, 2022 | -172.64% |
| Dec 31, 2021 | 37.97% |
| Sep 30, 2021 | -175.97% |
| Jun 30, 2021 | -76.23% |
| Dec 31, 2020 | -216.18% |
| Sep 30, 2020 | -229.66% |